Advanced search
Publication Cover
Annals of Human Biology Volume 29, 2002 - Issue 5
Submit an article Journal homepage
17
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Association of a single nucleotide variant in the human tumour necrosis factor alpha promoter region with decreased bone mineral density

N. Ota Department of Molecular Biology, Institute of Gerontology, Nippon Medical School, 1-396 Kosugi-cho, Nakahara-ku, Kawasaki 211-8533, Japan; Department of Orthopedics, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, Japan
,
T. Nakajima Department of Molecular Biology, Institute of Gerontology, Nippon Medical School, 1-396 Kosugi-cho, Nakahara-ku, Kawasaki 211-8533, Japan
,
Y. Ezura Department of Molecular Biology, Institute of Gerontology, Nippon Medical School, 1-396 Kosugi-cho, Nakahara-ku, Kawasaki 211-8533, Japan
,
H. Iwasaki Department of Molecular Biology, Institute of Gerontology, Nippon Medical School, 1-396 Kosugi-cho, Nakahara-ku, Kawasaki 211-8533, Japan
,
T. Suzuki Tokyo Metropolitan Institute of Gerontology and Hospital, Itabashi-ku, 173-0015, Tokyo, Japan
,
T. Hosoi Tokyo Metropolitan Institute of Gerontology and Hospital, Itabashi-ku, 173-0015, Tokyo, Japan
,
H. Orimo Tokyo Metropolitan Institute of Gerontology and Hospital, Itabashi-ku, 173-0015, Tokyo, Japan
,
S. Inoue Department of Geriatrics, Faculty of Medicine, University of Tokyo, Hongo, Tokyo, Japan
,
H. Ito Department of Orthopedics, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, Japan
&
M. Emi Department of Molecular Biology, Institute of Gerontology, Nippon Medical School, 1-396 Kosugi-cho, Nakahara-ku, Kawasaki 211-8533, Japan; Department of Orthopedics, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, Japan
 show all
Pages 550-558 | Published online: 09 Jul 2009

  • BERTOLINI, D. R., NEDWIN, G. E., BRINGMAN, T. S., SMITH, D. D., and MUNDY, G. R., 1986, Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors. Nature, 319, 516-518.
  • BEUTLER, B. A., 1992, Application of transcriptional and posttranscriptional reporter constructs to the analysis of tumor necrosis factor gene regulation. American Journal of Medical Science, 303, 129133.
  • BRAUN, N., MICHEL, U., ERNST, B. P., METZNER, R., BITSCH, A., WEBER, F., and RIECKMANN, P., 1996, Gene polymorphism at position -308 of the tumor necrosis factor (TNF-alpha) in multiple sclerosis and its influence on the regulation of TNF-alpha production. Neuroscience Letters, 215, 75-78.
  • COHEN-SOLAL, M. E., GRAULET, A. M., DENNE, M. A., GUERIS, J., BAYLINK, D., and DE VERNEJOUL, M. C., 1993, Peripheral monocyte culture supematants of menopausal women can induce bone resorption: involvement of cytokines. Journal of Clinical Endocrinology and Metabolism, 77, 16481653.
  • D'ALFONSO, S., COLOMBO, G., DELLA BELLA, S., SCROZA, R., and MOMIGLIANO-RICHIARDI, P., 1996, Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population. Tissue Antigens, 47, 551-555.
  • DEVOTO, M., SHIMOYA, K., CAMINI, J., OTT, J., TENENHOUSE, A., WHYTE, M. P., SEREDA, L., HALL, S., CONSIDINE, E., WILLIAMS, C. J., TROMP, G., KUIVANIEMI, H., ALA-KOKKO, L., PROCKOP, D. J., and SPOTILA, L. D., 1993, First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q. Human Molecular Genetics, 6, 151-157.
  • DOHI, Y., IKI, M., OHGUSHI, H., TABATA, S., KAJITA, E., NISHIMOTO, H., and YONEMASU, K., 1998, A novel polymorphism in the promoter region for human osteocalcin gene: the possibility of a correlation with bone mineral density in postmenopausal Japanese women. Journal of Bone and Mineral Research, 13, 1633-1639.
  • DUNCAN, E. L., BROWN, M. A., SINSHEIMER, J., BELL, J., CARR, A. J., WORDSWORTH, B. P., and WASS, J. A., 1999, Suggestive linkage of the parathyroid receptor type 1 to osteoporosis. Journal of Bone and Mineral Research, 14, 1993-1999.
  • ECONOMOU, J. S., 1989, Genetic analysis of the human tumor necrosis factor alpha/cachectin promoter region in a macrophage cell line. Journal of Experimental Medicine, 170, 321-326.
  • GRANT, S. F. A., REID, D. M., BLAKE, G., HERD, R., FOGELMAN, I., and RALSTON, S. H., 1996, Reduced bone density and osteoporosis associated with a polymorphic SpI site in the collagen type I alpha 1 gene. Nature Genetics, 14, 203-205.
  • HIGUCHI, T., SEKI, N., KAMIZONO, S., YAMADA, A., KIMURA, A., KATO, H., and ITO, K., 1998, Polymorphism of the 5'-flanking region of the human tumor necrosis factor alpha gene in Japanese. Tissue Antigens, 51, 605-612.
  • HÖHLER, T., KRUGER, A., GERKEN, G., SCHNEIDER, P. M., BÜSCHENFELDE, K. H. M., and RITTNER, C., 1998. Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis infection. Journal of Virology, 54, 173-177.
  • HOPKINS, P. N., WU, L. L., STEPHENSON, S. H., XIN, Y., KATSUMATA, H., NOBE, Y., YAMAKI, E., HIRAYAMA, T., EMI, M., and WILLIAMS, R. R., 1999, A novel LDLR mutation, H190Y, in a Utah kindred with familial hypercholesterolemia. Journal of Human Genetics, 44, 364-367.
  • HOSOI, T., MIYAO, M., INOUE, S., HOSHINO, S., SHIRAKI, M., ORIMO, H., and OUCHI, Y., 1999, Association study of parathyroid hormone gene polymorphism and bone mineral density in Japanese postmenopausal women. Calcified Tissue International, 64, 205-208.
  • JACOB, C. O., FROKEN, Z., LEWIS, G. D., Koo, M., HANSEN, J. A., and McDEVITT, H. O., 1990, Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proceedings of the National Academy of Sciences of the USA, 87, 1233-1237.
  • JONGENEEL, C. V., 1995, Transcriptional regulation of the tumor necrosis factor alpha gene. Immunobiology, 193, 210-216.
  • JOHNSON, R. A., BOYCE, B. F., MUNDY, G. R., and ROODMAN, G. D., 1989, Tumor producing human tumor necrosis factor induced hypercalcemia and osteoclastic bone resorption in nude mice. Endocrinology, 124, 1424-1427.
  • KAIJZEL, E. L., VAN KRUGTEN, M. V., BRINKMAN, B. M., HUIZINGA, T. W., VAN DER STAATEN, T., HAZES, J. M., ZIEGLER-HEITBROCK, H. W. et al., 1998, Functional analysis of a human tumor necrosis factor alpha (TNF-alpha) promoter polymorphism related to joint damage in rheumatoid arthritis. Molecular Medicine, 4, 724-733.
  • KEEN, R. W., WOODFORD-RICHENS, K. L., LAUNCHBURY, J. S., and SPECTOR, T. D., 1998, Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine. Bone, 23, 367-371.
  • KLEINBAUM, D. G., KUPPER, L. L., and MULLER, K. E., 1988, Applied Regression Analysis and Other Multivariate Methods, 2nd edn (Boston: PWS-KENT Publishing), pp. 299-301.
  • KOLLER, D. L., ECONS, M. J., MORIN, P. A., CHRISTIAN, J. C., HUI, S. L., PARRY, P., CURRAN, M. E., RODRIGUEZ, L. A., CONNEALLY, P. M., JOSLYN, G., PEACOCK, M., JOHNSTON, C. C., and FOROUD, T., 2000, Genome screen for QTLs contributing to normal variation in bone mineral density and osteoporosis. Journal of Clinical Endocrinology and Metabolism, 85, 3116-3120.
  • KROEGER, K. M., CARVILLE, K. S., and ABRAHAM L. J., 1997, The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Molecular Immunology, 34, 391-399.
  • LUBEN, R. A., MUNDY, G. R., TRUMMEL, C. L., and RAISZ, L. G., 1974, partial purification of osteoclastactivating factor from phytohemagglutinin-stimulated human leukocytes. Journal of Clinical Investigation, 53, 1473-1480.
  • MASI, L., BECHERINI, L., GENNARI, L., COLLI, E., MANSANI, R., FALCHETTI, A., CEPOLLARO, C., GONNELLI, S., TANINI, A., and BRANDI M. L., 1998, Allelic variants of human calcitonin receptor: distribution and association with bone mass in postmenopausal Italian women. Biochemical and Biophysical Research Communications, 245, 622-626.
  • McGUIRE, W., HILL, A. V., ALLSOPP, C. E., GREENWOOD, B. M., and KWIATKOWSKI, D., 1994, Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature, 371, 508-810.
  • MIRA, J. P., CARIOU, A., GRALL, F., DELCLAUX, C., LOSSER, M. R., HESHMATI, F., CHEVAL, C. et al., 1999, Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. Journal of the American Medical Association, 282, 561-568.
  • MIYAO, M., HOSOI, T., INOUE, S., HOSHINO, S., SHIRAKI, M., ORIMO, H., and OUCHI, Y., 1998, Polymorphism of insulin-like growth factor I gene and bone mineral density. Calcified Tissue International, 63, 306-311.
  • MIYAO, M., HOSOI, T., EMI, M., NAKAJIMA, T., INOUE, S., HOSHINO, S., SHIRAKI, M., ORIMO, H., and OUCHI, Y., 2000, Association of bone mineral density with a dinucleotide repeat polymorphism at the calcitonin (CT) locus. Journal of Human Genetics, 45, 346-350.
  • MORRISON, N. A., QI, J. C., TOKITA, A., KELLY, P. J., CROFTS, L., NGUYEN, T. V., SAMBROOK, P. N. et al., 1994, Prediction of bone density from vitamin D receptor alleles. Nature, 367, 284-287.
  • MUNDY G. R., 1991, Inflammatory mediators and the destruction of bone. Journal of Periodontal Research, 26, 213-217.
  • NIU, T., CHEN, C., CORDELL, H., YANG, J., WANG, Z., FANG, Z., SCHORK, N. J., ROSEN, C. J., and XU, X., 1999, A genome-wide scan for loci linked to forearm bone density. Human Genetics, 104, 226-233.
  • OGAWA, S., URANO, T., HOSOI, T., MIYAO, M., HOSHINO, S., FUJITA, M., SHIRAKI, M., ORIMO, H., OUCHI, Y., and INOUE, S., 1999, Association of bone mineral density with a polymorphism of the peroxisome proliferator-activated receptor gamma gene: PPAR gamma expression in osteoblasts. Biochemical and Biophysical Research Communications, 260, 122-126.
  • ORIMO, H., SUGIOKA, Y., FUKUNAGA, H., MUTOU, Y., FUTUBUCHI, T., ITURAI, I., NAKAMURA, T. et al., 1996, The diagnosis of osteoporosis. Japanese Journal of Bone and Mineral Research, 14, 219-233.
  • OTA, N., HUNT, S. C, NAKAJIMA, T., SUZUKI, T., HOSOI, T., SHIRAI, Y., and EMI, M., 2000, Linkage of human tumor necrosis factor-alpha to human osteoporosis by sib-pair analysis. Genes and Immunity, 1, 260-264.
  • OTA, N., NAKAJIMA, T., NAKAZAWA, I., SUZUKI, T., HOSOI, T., ORIMO, H., INOUE, S., SHIRAI, Y., and EMI, M., 2001, A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone-mineral density. Journal of Human Genetics, 46, 270-272.
  • PFEILSCHIFTER, J., CHENU, C., BIRD, A., MUNDY, G. R., and ROODMAN, G. D., 1989, lnterleukin-1 and tumor necrosis factor stimulate the formation of human osteoclast-like cells in vitro. Journal of Bone and Mineral Research, 4, 113-118.
  • POCOCK, N. A., EISMAN, J. A., HOPPER, J. L., YEATES, M. G., SAMBROOK, P. N., and EBERL, S., 1987, Genetic determinants of bone mass in adults. A twin study. Journal of Clinical Investigation, 80, 706-710.
  • PROCIOT, F., BRIANT, L., JONGENEEL, C. V., MOLVIG, J., WORSAAE, H., ABBAL, M., THOMSEN, M., NEURP, J., and CAMBON-THOMSEN, A., 1993, Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. European Journal of Immunology, 23, 224-231.
  • RAISZ, L. G., 1988, Local and systemic factors in the pathogenesis of osteoporosis. New England. Journal of Medicine, 318, 818-828.
  • RALSTON, S., 1994, Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced cytokine expression in postmenopausal osteoporosis. Journal of Bone and Mineral Research, 9, 883-890.
  • RALSTON, S. H., RUSSELL R. G., and GOWEN, M., 1990, Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women. Journal of Bone and Mineral Research, 5, 983-988.
  • ROBERTS, A. K., MONOZON-BORDONABA, F., VAN DEERLIN, P. G., HOLDER, J., MACONES, G. A., MORGAN, M. A., STRAUSS, J. F., 3rd et al., 1999, Association of polymorphism within the promoter of the tumor necrosis factor alpha gene with increased risk of the fetal membranes. American Journal of Obstetrics and Gynecology, 180, 1297-1302.
  • SANO, M., INOUE, S., HOSOI, T., OUCHI, Y., EMI, M., SHIRAKI, M., and ORIMO, H., 1995, Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. Biochemical and Biophysical Research Communications, 217, 378-383.
  • SEKI, N., YAMAGUCHI, K., YAMADA, A., KAMIZONO, S., SUGITA, S., TAGUCHI, C., MATSUOKA, M., MATSUMOTO, H., NISHIZAKA, S., ITOH, K., and MOCHIZUKI, M., 1999, Polymorphism of the 5'flanking region of the tumor necrosis factor (TNF)-alpha gene and susceptibility to human T-cell lymphotropic virus type I (HTLV-I) uveitis. Journal of Infectious Disease, 180, 880-883.
  • SLEMENDA, C. W., CHRISTIAN, J. C., WILLIAMS, C. J., NORTON, J. A., and JOHNSTON, C. C., JR, 1991, Genetic determinants of bone mass in adult women: a reevaluation of the twin model and the potential importance of gene interaction on heritability estimates. Journal of Bone and Mineral Research, 6, 561-567.
  • TABOULET, J., FRENKIAN, M., FRENDO, J. L., FEINGOLD, N., JULLIENNE, A., and DE VERNEJOUL, M. C., 1998, Calcitonin receptor polymorphism is associated with a decreased fracture risk in post-menopausal women. Human Molecular Genetics, 7, 2129-2133.
  • TSUJI, S., MUNKHBAT, B., HAGIHARA, M., TSURITANI, I., ABE, H., and TSUJI, K., 1998, HLA-A*24B*07-DRB1*01 haplotype implicated with genetic disposition of peak bone mass in healthy young Japanese women. Human Immunology, 59, 243-249.
  • TSUKAMOTO, K., YOSIDA, H., WATANABE, S., SUZUKI, T., MIYAO, M., HOSOI, T., ORIMO, H., and EMI, M., 1999, Association of radial bone mineral density with CA repeat polymorphism at the interleukin 6 locus in postmenopausal Japanese women. Journal of Human Genetics, 44, 148-151.
  • TSUKAMOTO, K., HARUTA, K., SHIBA, T., and EMI, M., 1998, Isolation and mapping of a polymorphic CA repeat sequence at the human interleukin 6 locus. Journal of Human Genetics, 43, 71-72.
  • WILSON, A. G., DI GIOVINE, F. S., BLAKENBORE, A. I. F., and DUFF, G. W., 1992, Single base polymorphism in the human tumor necrosis factor alpha (TNF alpha) gene detectable by Nco I restriction of PCR product. Human Molecular Genetics, 1, 353-354.
  • WILSON, A. G., SYMONS, J. A., MCDOWELL, T. L., McDEVITT, H. O., and DUFF, G. W., 1997, Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proceedings of the National Academy of Sciences of the USA, 94, 3195-3199.
  • YAMADA, Y., MIYAUCHI, A., GOTO, J., TAKAGI, Y., OKUIZUMI, H., KANEMATSU, M., HASE, M., TAKAI, H., HARADA, A., and IKEDA, K., 1998, Association of a polymorphism of the transforming growth factor-beta 1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. Journal of Bone and Mineral Research, 13, 1569-1576.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.